Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
MetricValuePeriodScopeSource row
Revenue¥1.3bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥2.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income−¥149m2024-04-01 → 2024-09-30Cons.Operating income
Operating income−¥242m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income−¥103m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥40m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥70m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax−¥103m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥62m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥104m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥31m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥61m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income−¥104m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥61m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥9.4bnat 2024-09-30Cons.Assets
Total assets¥9.1bnat 2024-03-31Cons.Assets
Total assets¥8.4bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥679mat 2024-09-30Cons.Liabilities
Total liabilities¥741mat 2024-03-31Cons.Liabilities
Net assets / equity¥8.7bnat 2024-09-30Cons.Net assets
Net assets / equity¥8.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥7.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥3.0bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥2.9bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥3.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥131m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥11m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥58m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥412m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥404m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥46m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥681m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥544m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-1.142024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.372023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.712023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio92.8%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio91.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2024-04-01 → 2024-09-30−¥378m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥176m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥176m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥8m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥267m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.3bn
—segment totalsegment ordinary income2024-04-01 → 2024-09-30¥275m
Reconciling Itemsreconcilingsegment ordinary income2023-04-01 → 2023-09-30−¥214m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥110m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥174m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment ordinary income2023-04-01 → 2023-09-30¥284m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 483
ItemContextValueUnit
Comprehensive incomePrior1YTDDuration169220000JPY
Comprehensive incomeCurrentYTDDuration-249246000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration169220000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-249246000JPY
Income before income taxesPrior1YTDDuration61926000JPY
Income before income taxesCurrentYTDDuration-103257000JPY
Amortization of goodwill ope cfPrior1YTDDuration1356000JPY
Amortization of goodwill ope cfCurrentYTDDuration1356000JPY
Depreciation and amortization ope cfPrior1YTDDuration16264000JPY
Depreciation and amortization ope cfCurrentYTDDuration20406000JPY
Share based compensation expenses ope cfPrior1YTDDuration25979000JPY
Share based compensation expenses ope cfCurrentYTDDuration25187000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-6909000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-6768000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration-237000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration4159000JPY
Interest income ope cfPrior1YTDDuration-23921000JPY
Interest income ope cfCurrentYTDDuration-31160000JPY
Subsidy income ope cfPrior1YTDDuration-204772000JPY
Subsidy income ope cfCurrentYTDDuration-14611000JPY
Loss gain on sales and retirement of noncurrent assets ope cfPrior1YTDDuration-JPY
Loss gain on sales and retirement of noncurrent assets ope cfCurrentYTDDuration29000JPY
Loss gain on investments in partnership ope cfPrior1YTDDuration720000JPY
Loss gain on investments in partnership ope cfCurrentYTDDuration-JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration2404000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration3735000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration-39798000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration22707000JPY
Loss gain on valuation of investment securities ope cfPrior1YTDDuration8349000JPY
Loss gain on valuation of investment securities ope cfCurrentYTDDuration-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration134313000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration47034000JPY
Decrease increase in inventories ope cfPrior1YTDDuration20447000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-35966000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-74879000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-47523000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration-89851000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration-7829000JPY
Increase decrease in other current liabilities ope cfPrior1YTDDuration-2665000JPY
Increase decrease in other current liabilities ope cfCurrentYTDDuration8716000JPY
Other net ope cfPrior1YTDDuration2690000JPY
Other net ope cfCurrentYTDDuration-81228000JPY
Subtotal ope cfPrior1YTDDuration-168582000JPY
Subtotal ope cfCurrentYTDDuration-195013000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration23921000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration31160000JPY
Proceeds from subsidy ope cfPrior1YTDDuration204772000JPY
Proceeds from subsidy ope cfCurrentYTDDuration34609000JPY
Income taxes paid ope cfPrior1YTDDuration-1880000JPY
Income taxes paid ope cfCurrentYTDDuration-1913000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass